LAYLA tablet

DRUG2 trials

Sponsors

PMG Pharm Co., Ltd

Conditions

Osteoarthritis of the Knee

Phase 4

To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients

CompletedNCT01768468

PMG Pharm Co., LtdOsteoarthritis of the Knee

Start: 2012-10-31End: 2013-09-30Updated: 2013-10-14

To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee

CompletedNCT02049606

PMG Pharm Co., LtdOsteoarthritis of the Knee

Start: 2014-02-24End: 2016-05-30Updated: 2017-09-20

Related Papers

Prospective, randomized, double-blinded, double-dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis.

2016-01-2512 citations